APA (7th ed.) Citation

Stage, C., Dalhoff, K., Schow Guski, L., Rasmussen, H. B., Bjerre, D., Ferrero‐Miliani, L., . . . Jürgens, G. (2019). The impact of human CES1 genetic variation on enzyme activity assessed by ritalinic acid/methylphenidate ratios. Basic & Clinical Pharmacology & Toxicology, 125(1), 54. https://doi.org/10.1111/bcpt.13212

Chicago Style (17th ed.) Citation

Stage, Claus, Kim Dalhoff, Louise Schow Guski, Henrik Berg Rasmussen, Ditte Bjerre, Laura Ferrero‐Miliani, Majbritt Busk Madsen, Ragnar Thomsen, and Gesche Jürgens. "The Impact of Human CES1 Genetic Variation on Enzyme Activity Assessed by Ritalinic Acid/methylphenidate Ratios." Basic & Clinical Pharmacology & Toxicology 125, no. 1 (2019): 54. https://doi.org/10.1111/bcpt.13212.

MLA (9th ed.) Citation

Stage, Claus, et al. "The Impact of Human CES1 Genetic Variation on Enzyme Activity Assessed by Ritalinic Acid/methylphenidate Ratios." Basic & Clinical Pharmacology & Toxicology, vol. 125, no. 1, 2019, p. 54, https://doi.org/10.1111/bcpt.13212.